Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BIOTRONIK Announces the First Implantation of the PHYLAX AV ICD in the United States.


LAKE OSWEGO, Ore.--(BUSINESS WIRE)--Feb. 8, 1999--BIOTRONIK, Inc. announced today the first implantation of the PHYLAX AV, a dual-chamber implantable cardioverter defibrillator (ICD ICD International Classification of Diseases (of the World Health Organization); intrauterine contraceptive device.

ICD
abbr.
) on February 5, 1999.

The PHYLAX AV ICD was implanted in a patient who survived a recent Cardiac Sudden Death episode as a result of developing ventricular fibrillation, a condition in which the heart beats dangerously fast, which could be fatal to the patient.

The PHYLAX AV introduces a new era of intelligent AV discrimination with SMART Detection(TM). SMART Detection(TM) provides a unique algorithm to differentiate heart rhythms by comparing activity in the atria Atria
The heart has four chambers. The right and left atria are at the top of the heart and receive returning blood from the veins. The right and left ventricles are at the bottom of the heart and act as the body's main pumps.
 and ventricles Ventricles
The two chambers of the heart that are involved in pumping blood. The right ventricle pumps blood into the lungs to receive oxygen. The left ventricle pumps blood into the circulation of the body to deliver oxygen to all of the body's organs and tissues.
 to ascertain the origin of the heart rhythm and determine the appropriate therapy. This algorithm results in increased specificity without compromising sensitivity. The SMART Detection(TM) evaluates each individual event, taking into account not only the atrial and ventricular rhythms, but also the relationship between the two rhythms. The PHYLAX AV is a dual-chamber ICD capable of treating dangerous heart rhythms by providing antitachycardia pacing (high rate pacing) or defibrillation Defibrillation Definition

Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm.
 therapy to restore the normal rhythm of the heart.

In addition to the SMART Detection(TM) Algorithm, the PHYLAX AV provides dual-chamber pacing with Dynamic Hysteresis and Dynamic AV Delay to optimize hemodynamics hemodynamics /he·mo·dy·nam·ics/ (-di-nam´iks) the study of the movements of blood and of the forces concerned.hemodynam´ic

he·mo·dy·nam·ics
n.
. The Phylax AV features Automatic Mode Conversion for atrial tachyarrhythmias, a mode switch counter, and event counters. Extensive stored data includes up to 16 minutes of electrograms with event markers along with episode information regarding detection and therapy. Tachycardia therapies include 30 joules of delivered energy and multiple antitachycardia treatment schemes, which is delivered upon detection of the fast heart rhythm. The Phylax AV is implanted using the TMS 1000, Tachyarrhythmia tachyarrhythmia /tachy·ar·rhyth·mia/ (tak?e-ah-rith´me-ah) any disturbance of the heart rhythm in which the heart rate is abnormally increased.

tach·y·ar·rhyth·mi·a
n.
 Monitoring System, the first complete implant and follow-up analyzer and programmer.

BIOTRONIK, a world leader in the cardiovascular device industry, is committed to the research and development of new biomedical products. The company's U.S. Headquarters is located in Lake Oswego, Oregon Lake Oswego (IPA: ɔs wiː ɡo) is a city in Clackamas County, Oregon, United States. (Small parts of the city extend into Multnomah County to the north and Washington County to the west. , with Worldwide Headquarters in Berlin, Germany.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 8, 1999
Words:324
Previous Article:Asterion Signs Multi-Year Contract with Medalia HealthCare.
Next Article:Manufacturer of the Blood Bank Gel TestTM Announces Patent Infringement Suit.



Related Articles
BIOTRONIK receives IDE approval to start the Phylax 06 clinical study.
BIOTRONIK Receives Approval for the Tachyarrhythmia Monitoring System, TMS 1000.
BIOTRONIK Receives Approval for Phylax AV Implantable Defibrillator.
Coverage of Urinary Incontinence Treatment. (Featured CME Topic: Urinary Incontinence).
Talking in code: will a mandate to update the national medical coding system help health-care providers and minimize the coder shortage--or add...
Rhe-1. Enterococcal pacemaker endocarditis in a patient on etanercept.
Ejection fraction and QRS width as predictors of event rates in patients with implantable cardioverter defibrillators.
Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators.
Sudden cardiac death.
Ready, set, go? Most health plans agree that migration to a new coding system--ICD-10--is a step in the right direction, but they fear a proposed...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles